122 related articles for article (PubMed ID: 1823715)
1. [Synthesis and platelet aggregation inhibitory activity of analogues of 4-([2-(1H-imidazol-1-yl)-1-(4-substituted-phenyl)ethoxy]methyl)benzoic acids].
Wu QY; Yang JQ
Yao Xue Xue Bao; 1991; 26(10):741-6. PubMed ID: 1823715
[TBL] [Abstract][Full Text] [Related]
2. New chiral inhibitors of induced platelet aggregation: the enantiomeric specificity of (R)- and (S)-methyl and ethyl esters of 1-(4-[(1-hydroxycarbonyl)-ethoxy]-benzyl)-1H-1,2,3-triazole as a tool for determining their biological target.
Biagi G; Giorgi I; Livi O; Scartoni V; Catalani R; Gervasi G
Farmaco; 1996 Dec; 51(12):761-6. PubMed ID: 9050207
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
Dickinson RP; Dack KN; Long CJ; Steele J
J Med Chem; 1997 Oct; 40(21):3442-52. PubMed ID: 9341919
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
[TBL] [Abstract][Full Text] [Related]
5. [Synthesis and platelet aggregation inhibitory activity of 6-substituted dihydropyridazinones].
Yao FM; Sun CS
Yao Xue Xue Bao; 1993; 28(7):548-52. PubMed ID: 8285059
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and platelet aggregation inhibitory effects of N-[(1H-pyrazol-1-yl)alkyl]benzoylamides.
Ferroni R; Milani L; Simoni D; Orlandini P; Bottura M; Bardi A; Guarneri M
Arzneimittelforschung; 1990 Jun; 40(6):705-9. PubMed ID: 2397007
[TBL] [Abstract][Full Text] [Related]
7. Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors.
Soyka R; Guth BD; Weisenberger HM; Luger P; Müller TH
J Med Chem; 1999 Apr; 42(7):1235-49. PubMed ID: 10197967
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis and platelet aggregation inhibitory activity of 6-(4-substituted phenyl)-4,5-dihydro-3(2H)-pyridazinones].
Jiang Q; Sun CS
Yao Xue Xue Bao; 1990; 25(8):598-603. PubMed ID: 2082682
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships in an imidazole-based series of thromboxane synthase inhibitors.
Manley PW; Allanson NM; Booth RF; Buckle PE; Kuzniar EJ; Lad N; Lai SM; Lunt DO; Tuffin DP
J Med Chem; 1987 Sep; 30(9):1588-95. PubMed ID: 3305945
[TBL] [Abstract][Full Text] [Related]
10. Rational Design and Synthesis of 1-(Arylideneamino)-4-aryl-1H-imidazole-2-amine Derivatives as Antiplatelet Agents.
Amidi S; Esfahanizadeh M; Tabib K; Soleimani Z; Kobarfard F
ChemMedChem; 2017 Jun; 12(12):962-971. PubMed ID: 28494138
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane synthase inhibitors. Synthesis and pharmacological activity of (R)-, (S)-, and (+/-)-2,2-dimethyl-6-[2-(1H-imidazol-1-yl)-1-[[(4-methoxyphenyl)- methoxy]methyl]ethoxy]hexanoic acids.
Manley PW; Tuffin DP; Allanson NM; Buckle PE; Lad N; Lai SM; Lunt DO; Porter RA; Wade PJ
J Med Chem; 1987 Oct; 30(10):1812-8. PubMed ID: 3656356
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives.
Chen HS; Kuo SC; Teng CM; Lee FY; Wang JP; Lee YC; Kuo CW; Huang CC; Wu CC; Huang LJ
Bioorg Med Chem; 2008 Feb; 16(3):1262-78. PubMed ID: 17988878
[TBL] [Abstract][Full Text] [Related]
13. [(1H-imidazol-1-yl)methyl]- and [(3-pyridinyl)methyl]pyrroles as thromboxane synthetase inhibitors.
Martinez GR; Walker KA; Hirschfeld DR; Maloney PJ; Yang DS; Rosenkranz RP
J Med Chem; 1989 Apr; 32(4):890-7. PubMed ID: 2704033
[TBL] [Abstract][Full Text] [Related]
14. Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazoles.
Cross PE; Dickinson RP; Parry MJ; Randall MJ
J Med Chem; 1985 Oct; 28(10):1427-32. PubMed ID: 3930740
[TBL] [Abstract][Full Text] [Related]
15. Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists.
Curtin ML; Davidsen SK; Heyman HR; Garland RB; Sheppard GS; Florjancic AS; Xu L; Carrera GM; Steinman DH; Trautmann JA; Albert DH; Magoc TJ; Tapang P; Rhein DA; Conway RG; Luo G; Denissen JF; Marsh KC; Morgan DW; Summers JB
J Med Chem; 1998 Jan; 41(1):74-95. PubMed ID: 9438024
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
17. Effect of SC 38249, a novel substituted imidazole, on platelet aggregation in vitro and in vivo.
Lad N; Honey AC; Lunt DO; Booth RF; Westwick J; Manley PW; Tuffin DP
Thromb Haemost; 1988 Apr; 59(2):164-70. PubMed ID: 3133807
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
[TBL] [Abstract][Full Text] [Related]
19. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, identification and antiplatelet evaluation of 2-morpholino substituted benzoxazines.
Pritchard KM; Al-Rawi J; Bradley C
Eur J Med Chem; 2007 Sep; 42(9):1200-10. PubMed ID: 17336427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
